Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson’s Disease Mice via Inhibiting TLR4/NF-κB Signaling

Zhu-qing He(Shanghai University of Traditional Chinese Medicine), Jiancheng He(Nantong University)

Neurochemical Research

August 10, 2023

10.1007/s11064-023-04004-9

Cited by 14

Related Papers

ECHDC2 inhibits the proliferation of gastric cancer cells by binding with NEDD4 to degrade MCCC2 and reduce aerobic glycolysis

|Molecular Medicine|2024|20

β-Elemene promotes ferroptosis and reverses radioresistance in gastric cancer by inhibiting the OTUB1-GPX4 interaction

|Frontiers in Pharmacology|2024|18

Integrated network pharmacology and transcriptomics to explore the mechanism of compound Dihuang granule (CDG) protects dopaminergic neurons by regulating the Nrf2/HMOX1 pathway in the 6-OHDA/MPP+-induced model of Parkinson’s disease

|Chinese Medicine|2024|5

Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson's Disease Mice via Inhibiting TLR4/NF-κB Signaling

|Research Square|2022|0